BABA vs PMCB · P/E 20, rev $137.30B vs $8.6M cap
Alibaba Group Holding Ltd (BABA) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
BABA currently screens at market cap $305.19B and trailing P/E 19.6. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the BABA and PMCB stock pages for the full models.
Not investment advice.